- Prescriptions
- Generic Prescriptions
Depot medroxyprogesterone acetate injection is a contraceptive injection. It is similar to the hormone called progesterone, which is produced in the body by the ovaries. The contraceptive injection mainly works by stopping the ovaries from releasing an egg (ovulation). The contraceptive injections are much more effective than oral one. Their effectiveness ranges from 94% to 99%. These injections are taken after every twelve week time period. However, lack of resources such as trained nurses or healthcare professionals and infrastructure to administer injectable contraceptives in several developing and underdeveloped countries may hinder the growth of the market over forecast period. Also, availability of alternative contraceptive methods such as condoms, IUCDs, oral contraceptives may also restrain the market growth.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The factors which are streaming the growth of this market are growing awareness among urban young woman, who are intended postpone pregnancy, increase in disposable income in developing countries and growing middle class population in emerging countries, and increasing collaboration between public, private, and non-governmental organization effectively helping to improve the access to medication in resource constrained and underdeveloped countries.
The depot medroxyprogesterone acetate injection market key players are: Pfizer Inc., Fangtong Pharma.Co. Ltd, Gador S.A., Sigma-Aldrich Co. LLC., Teva Pharmaceutical Industries Ltd., Greenstone LLC, Serum Internation Ltd., West-Coast Pharmaceutical, Arrow Pharma Group,, Zuche Pharmaceuticals Pvt. Ltd.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1.Executive Summary |
2.Global Depot Medroxyprogesterone Acetate Injection Market Introduction |
2.1.Global Depot Medroxyprogesterone Acetate Injection Market - Taxonomy |
2.2.Global Depot Medroxyprogesterone Acetate Injection Market - Definitions |
2.2.1.Type |
2.2.2.End User |
2.2.3.Region |
3.Global Depot Medroxyprogesterone Acetate Injection Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Depot Medroxyprogesterone Acetate Injection Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Depot Medroxyprogesterone Acetate Injection Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Prescriptions |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Generic Prescriptions |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Depot Medroxyprogesterone Acetate Injection Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Hospital |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Pharmacy |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Depot Medroxyprogesterone Acetate Injection Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Depot Medroxyprogesterone Acetate Injection Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Prescriptions |
8.1.2.Generic Prescriptions |
8.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Hospital |
8.2.2.Pharmacy |
8.2.3.Others |
8.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Depot Medroxyprogesterone Acetate Injection Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Prescriptions |
9.1.2.Generic Prescriptions |
9.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Hospital |
9.2.2.Pharmacy |
9.2.3.Others |
9.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
10.Asia Pacific (APAC) Depot Medroxyprogesterone Acetate Injection Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Prescriptions |
10.1.2.Generic Prescriptions |
10.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Hospital |
10.2.2.Pharmacy |
10.2.3.Others |
10.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Depot Medroxyprogesterone Acetate Injection Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Prescriptions |
11.1.2.Generic Prescriptions |
11.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Hospital |
11.2.2.Pharmacy |
11.2.3.Others |
11.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Depot Medroxyprogesterone Acetate Injection Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Prescriptions |
12.1.2.Generic Prescriptions |
12.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Hospital |
12.2.2.Pharmacy |
12.2.3.Others |
12.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Pfizer Inc. |
13.2.2.Fangtong Pharma.Co. Ltd |
13.2.3.Gador S.A. |
13.2.4.Sigma-Aldrich Co. LLC. |
13.2.5.Teva Pharmaceutical Industries Ltd. |
13.2.6.Greenstone LLC |
13.2.7.Serum Internation Ltd. |
13.2.8.West-Coast Pharmaceutical |
13.2.9.Arrow Pharma Group, |
13.2.10.Zuche Pharmaceuticals Pvt. Ltd. |
14. Research Methodology |
15. Appendix and Abbreviations |